Castleview Partners’s MetLife MET Stock Holding History

Castleview Partners’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8	Closed	-$593	–	975
2024 Q1	$593	Buy	+8	New	+$558	﹤0.01%	830
2021 Q2	$15K	Buy	+250	New	+$15.8K	0.01%	608

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Castleview Partners's MET Position: Q2 2024 in Review

Castleview Partners sold out of MetLife (MET) in Q2 2024, closing a stake of 8 shares — an estimated $593 sold.

Castleview Partners first reported a position in MET in Q2 2021 and held it in 2 quarters. The position peaked at $15K in Q2 2021. 1,298 funds tracked by Wall St. Rank hold MET as of Q2 2024.

Castleview Partners reported no remaining MetLife position as of Q2 2024 after selling out during the quarter.
Castleview Partners sold 8 MetLife shares in Q2 2024, an estimated $593.
Castleview Partners first reported a position in MetLife in Q2 2021 and held it in 2 quarters.
Castleview Partners's MetLife position peaked at $15K in Q2 2021.
1,298 funds tracked by Wall St. Rank held MetLife as of Q2 2024.

Based on Castleview Partners's 13F filing for Q2 2024, filed 31 Jul 2024.